| The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR‐21 function by directly targeting its precursor D Bose, G Jayaraj, H Suryawanshi, P Agarwala, SK Pore, R Banerjee, ... Angewandte Chemie-International Edition 51 (4), 1019, 2012 | 204 | 2012 |
| Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism KB Singh, SH Kim, ER Hahm, SK Pore, BL Jacobs, SV Singh Carcinogenesis 39 (6), 826-837, 2018 | 52 | 2018 |
| Inflammasomes are important mediators of prostatic inflammation associated with BPH M Kashyap, S Pore, Z Wang, J Gingrich, N Yoshimura, P Tyagi Journal of inflammation 12, 1-8, 2015 | 49 | 2015 |
| Mitochondrial dysfunction in cancer chemoprevention by phytochemicals from dietary and medicinal plants A Sehrawat, R Roy, SK Pore, ER Hahm, SK Samanta, KB Singh, SH Kim, ... Seminars in cancer biology 47, 147-153, 2017 | 46 | 2017 |
| Disease subtype–independent biomarkers of breast cancer chemoprevention by the ayurvedic medicine phytochemical withaferin A SK Samanta, A Sehrawat, SH Kim, ER Hahm, Y Shuai, R Roy, SK Pore, ... JNCI: Journal of the National Cancer Institute 109 (6), djw293, 2017 | 41 | 2017 |
| BDNF overexpression in the bladder induces neuronal changes to mediate bladder overactivity MP Kashyap, SK Pore, WC de Groat, CJ Chermansky, N Yoshimura, ... American Journal of Physiology-Renal Physiology 315 (1), F45-F56, 2018 | 39 | 2018 |
| Structure− activity study to develop cationic lipid-conjugated haloperidol derivatives as a new class of anticancer therapeutics K Pal, SK Pore, S Sinha, R Janardhanan, D Mukhopadhyay, R Banerjee Journal of medicinal chemistry 54 (7), 2378-2390, 2011 | 37 | 2011 |
| Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect SK Pore, A Choudhary, B Rathore, A Ganguly, P Sujitha, CG Kumar, ... Biomaterials 34 (28), 6804-6817, 2013 | 31 | 2013 |
| Bladder overactivity involves overexpression of MicroRNA 132 and nerve growth factor M Kashyap, S Pore, M Chancellor, N Yoshimura, P Tyagi Life sciences 167, 98-104, 2016 | 24 | 2016 |
| Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate SK Pore, ER Hahm, JD Latoche, CJ Anderson, Y Shuai, SV Singh Carcinogenesis 39 (2), 134-145, 2018 | 21 | 2018 |
| Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells In Vitro and In Vivo KB Singh, ER Hahm, SK Pore, SV Singh Molecular cancer therapeutics 18 (10), 1800-1810, 2019 | 18 | 2019 |
| Advanced therapeutic directions to treat the underactive bladder PP Smith, P Tyagi, GA Kuchel, S Pore, C Chermansky, M Chancellor, ... International urology and nephrology 46, 35-44, 2014 | 18 | 2014 |
| Engineered reversal of drug resistance in cancer cells—metastases suppressor factors as change agents VK Yadav, A Kumar, A Mann, S Aggarwal, M Kumar, SD Roy, SK Pore, ... Nucleic acids research 42 (2), 764-773, 2013 | 18 | 2013 |
| Spontaneous recovery of reflex voiding following spinal cord injury mediated by anti-inflammatory and neuroprotective factors P Tyagi, K Kadekawa, M Kashyap, S Pore, N Yoshimura Urology 88, 57-65, 2016 | 17 | 2016 |
| Urine chemokines indicate pathogenic association of obesity with BPH/LUTS P Tyagi, SS Motley, M Kashyap, S Pore, J Gingrich, Z Wang, N Yoshimura, ... International urology and nephrology 47, 1051-1058, 2015 | 13 | 2015 |
| Characterization of mammalian N-degrons and development of heterovalent inhibitors of the N-end rule pathway Y Jiang, SK Pore, JH Lee, S Sriram, BK Mai, DH Han, P Agarwalla, ... Chemical Science 4 (8), 3339-3346, 2013 | 13 | 2013 |
| A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer–Induced Osteolytic Bone Resorption SK Pore, ER Hahm, SH Kim, KB Singh, L Nyiranshuti, JD Latoche, ... Molecular cancer therapeutics 19 (2), 420-431, 2020 | 10 | 2020 |
| Constitutive expression Of NGF And P75NTR affected by bladder distension and NGF antisense treatment M Kashyap, S Pore, N Yoshimura, P Tyagi Life sciences 148, 93-98, 2016 | 10 | 2016 |
| Amine as a bottom-line functionality on DDS surface for efficient endosomal escape and further subcellular targets SM Roy, S Barman, A Basu, T Ghatak, SK Pore, SK Ghosh, R Mukherjee, ... Journal of Drug Delivery Science and Technology 71, 103303, 2022 | 6 | 2022 |
| N‐end rule pathway inhibitor sensitizes cancer cells to antineoplastic agents by regulating XIAP and RAD21 protein expression SK Pore, A Ganguly, S Sau, S Godeshala, AK Kanugula, R Ummanni, ... Journal of Cellular Biochemistry 121 (1), 804-815, 2020 | 4 | 2020 |
Rajkumar BanerjeeCSIR-Indian Institute of Chemical TechnologyVerified email at iict.res.in
